CA2699403A1 - Pharmaceutical composition with anti-diabetic action - Google Patents

Pharmaceutical composition with anti-diabetic action Download PDF

Info

Publication number
CA2699403A1
CA2699403A1 CA2699403A CA2699403A CA2699403A1 CA 2699403 A1 CA2699403 A1 CA 2699403A1 CA 2699403 A CA2699403 A CA 2699403A CA 2699403 A CA2699403 A CA 2699403A CA 2699403 A1 CA2699403 A1 CA 2699403A1
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
methyl
carbethoxy
optionally substituted
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2699403A
Other languages
English (en)
French (fr)
Inventor
Alexander Victorovich Demin
Vitaly Afanasievich Martianov
Alexander Mihaylovich Shuster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZAKRYTOE AKTSIONERNOE OBSCHESTVO "MASTERCLONE"
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2699403A1 publication Critical patent/CA2699403A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA2699403A 2007-09-14 2008-05-22 Pharmaceutical composition with anti-diabetic action Abandoned CA2699403A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2007134267/15A RU2361581C2 (ru) 2007-09-14 2007-09-14 Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний
RU2007134267 2007-09-14
PCT/RU2008/000320 WO2009035368A1 (en) 2007-09-14 2008-05-22 Antidiabetic pharmaceutical composition

Publications (1)

Publication Number Publication Date
CA2699403A1 true CA2699403A1 (en) 2009-03-19

Family

ID=40452228

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2699403A Abandoned CA2699403A1 (en) 2007-09-14 2008-05-22 Pharmaceutical composition with anti-diabetic action

Country Status (11)

Country Link
US (1) US8247407B2 (https=)
EP (1) EP2204173B1 (https=)
JP (1) JP2010539160A (https=)
KR (1) KR20100086981A (https=)
CN (1) CN101801373B (https=)
AU (1) AU2008297608A1 (https=)
BR (1) BRPI0815200A2 (https=)
CA (1) CA2699403A1 (https=)
MX (1) MX2010002754A (https=)
RU (1) RU2361581C2 (https=)
WO (1) WO2009035368A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2361581C2 (ru) 2007-09-14 2009-07-20 Закрытое Акционерное Общество "Мастерклон" Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний
RU2421219C1 (ru) * 2009-11-19 2011-06-20 Закрытое Акционерное Общество "Мастерклон" Ингибиторы протеинкиназы с

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3510491A (en) * 1967-02-02 1970-05-05 Sterling Drug Inc 4-(cyclicaminomethyl)-5-hydroxyindole-3-carboxylic acids and esters thereof
US4226829A (en) * 1978-10-04 1980-10-07 Andrew Mike Renewable vaporizer for air treatment and the like
US4889286A (en) * 1988-09-19 1989-12-26 Donald Spector Controllable air freshener unit
FR2674522B1 (fr) * 1991-03-26 1993-07-16 Lipha Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant.
DE19753956A1 (de) * 1997-12-05 1999-06-17 Draeger Sicherheitstech Gmbh Duftpatrone
SE0104334D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
CN100457730C (zh) * 2002-08-29 2009-02-04 默克公司 具有抗糖尿病活性的吲哚化合物
AR041481A1 (es) 2002-10-07 2005-05-18 Hoffmann La Roche Derivados de acido arilpropionico-oxazol y su uso como agonistas de ppar
CA2502269C (en) 2002-10-18 2009-12-22 Merck & Co., Inc. Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
WO2005102320A1 (fr) 2004-04-21 2005-11-03 Zakrytoe Aktsionernoe Obschestvo 'masterklon' Medicament pour traiter des infections virales
US20060233538A1 (en) * 2005-04-14 2006-10-19 Tollens Fernando R Energized systems and devices for delivering volatile materials
WO2007075102A1 (en) 2005-12-28 2007-07-05 Zakrytoe Aktsionernoe Obschestvo 'masterklon' Medicinal agent for treating viral infections
US20070176015A1 (en) * 2006-01-30 2007-08-02 The Procter & Gamble Company System for delivering volatile materials
WO2007136302A2 (en) 2006-05-23 2007-11-29 Alla Chem, Llc Active substances, pharmaceutical composition and a method for the production and use thereof
US8329689B2 (en) 2006-05-23 2012-12-11 Alexandre Vasilievich Ivachtchenko Substituted indoles and a method for the production and use thereof
WO2008100977A2 (en) * 2007-02-14 2008-08-21 N.V. Organon Carbamates therapeutic release agents as amidase inhibitors
RU2344817C1 (ru) 2007-06-19 2009-01-27 Андрей Александрович Иващенко Замещенные эфиры 5-гидрокси-1н-индол-3-карбоновой кислоты, фармацевтическая композиция, способ их получения и применения
RU2361581C2 (ru) 2007-09-14 2009-07-20 Закрытое Акционерное Общество "Мастерклон" Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний

Also Published As

Publication number Publication date
EP2204173A1 (en) 2010-07-07
CN101801373A (zh) 2010-08-11
AU2008297608A1 (en) 2009-03-19
BRPI0815200A2 (pt) 2015-03-31
RU2361581C2 (ru) 2009-07-20
EP2204173A4 (en) 2010-12-29
JP2010539160A (ja) 2010-12-16
US8247407B2 (en) 2012-08-21
MX2010002754A (es) 2010-03-30
CN101801373B (zh) 2013-03-27
US20100168092A1 (en) 2010-07-01
EP2204173B1 (en) 2013-07-03
WO2009035368A1 (en) 2009-03-19
KR20100086981A (ko) 2010-08-02
RU2007134267A (ru) 2009-03-20

Similar Documents

Publication Publication Date Title
RU2245709C2 (ru) Применение аналогов сибутрамина для профилактики сахарного диабета
EP1377278B1 (en) Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv
CN107652283B (zh) 用于代谢综合征的治疗的化合物
RU2057120C1 (ru) N-алкил-3-фенил-3-(2-замещенный фенокси)пропиламин или его фармацевтически приемлемая кислотно-аддитивная соль, способ его получения, фармацевтическая композиция, обладающая ингибирующей поглощение норминефрина активностью
EP0687472A2 (en) Potentiation of drug response by a serotonin 1A receptor antagonist
EP0714663A2 (en) Potentiation of drug response by a serotonin 1A receptor antagonist
CZ20002392A3 (cs) Léčivo pro léčbu obezity a farmaceutický prostředek k tomuto účelu
JP2526059B2 (ja) 抗潰瘍剤
WO1997021439A1 (fr) Medicament destine au traitement des troubles obsessifs compulsifs, de l'apnee du sommeil, des dysfonctions sexuelles, de l'emese et du mal des transports
JP4418157B2 (ja) ビグアニド誘導体
EP2204173B1 (en) Antidiabetic pharmaceutical composition
WO1998027982A1 (en) Composition containing ascorbic acid
JPH05500055A (ja) ５―アミノ―１，２，３，４―テトラヒドロアクリジンの誘導体および医薬としての使用
KR20090087042A (ko) 알콜 남용, 중독 및 의존증 치료방법
US6197818B1 (en) Drug for treating diabetic nephrosis
CN102218062B (zh) 一种治疗糖尿病的药物组合物
JPH054917A (ja) 真正糖尿病およびそれに関連した症状を治療するための医薬調剤、およびその製造法
JPH0812573A (ja) 遊離脂肪酸低下剤
EP0818198A1 (en) Potentiation of drug response by increasing serotonin availability
WO2025186320A1 (en) Combinations of beta 2-adrenergic receptor agonists and sglt2 inhibitors for use in treating hyperglycaemia or a disorder characterized by hyperglycaemia
BE1004295A3 (fr) Utilisation des activateurs des canaux potassiques pour la prophylaxie de l'asthme.
CN119584967A (zh) 用甘氨酸转运抑制剂治疗肝性卟啉症的组合物和方法
AU2006261296B2 (en) Pharmaceutical composition comprising a 1-(3-chlorophenyl)-3-alkylpiperazine for treating apetite disorder
FR2624120A1 (fr) Nouveaux sels organogermaniques utiles comme medicaments notamment comme activateurs des osteoblastes
JPH06510540A (ja) 抗うつ薬としての多環状イミド

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20130522